drugset / Trial / NCT00389389
Phase I, Open-Label, Dose-Escalation Study of AZD4877 in Solid Tumors
Non-randomizedSingle-groupOpen-labelTreatment
Summary
The primary purpose of this study is to find out what the maximum tolerated dose is for an experimental drug called AZD4877 based on the side effects experiences by patients that receive AZD4877 on a weekly basis
Timeline
- Start
- 2006-09
- Primary completion
- 2008-08
- Completion
- 2008-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | AZD4877 | Small molecule | — | Intravenous |